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The RNA fragments persisted until end-stage disease but 
without necessarily eliciting a full immunologic response. 
The proportion of probe-positive biopsy specimens was 
higher in patients with dilated cardiomyopathy (41%) than in 
explanted hearts (2%). This finding might suggest, in accord 
with the results of Caforio et al. (I), that virus may be 
eliminated late in the disease. 
The evidence provided by progression from myocarditis 
to dilated cardiomyopathy clinically and hemodynamically, 
together with the molecular biologic data and immunologic 
studies, strongly suggests a causal role of viral infection. 
However, caution is still necessary because association does 
not inevitably imply causation and the virus-immune theory 
would explain no more than about 50% of cases of dilated 
cardiomyopathy. Because autoimmune disturbance can be 
inherited, Caforio et al. (I) should study relatives of their 
patients with dilated cardiomyopathy. It might be that 
there is a genetic basis in some patients with dilated cardio- 
myopathy and that viral infection acts as the trigger to 
precipitate a latent autoimmunologic destructive cardiac 
response. 
Conclusions. The enigma of dilated cardiomyopathy is 
not solved, although the work of Caforio and colleagues (1) 
provides an important landmark of progress both in the 
experimental field and in the clinical realm. The place of 
immunologic therapy and viral chemotherapy is being ex- 
plored and myocarditis is treated (sometimes incorrectly) 
with steroids. Furthermore, because patients after cardiac 
transplantation are immunologically depressed, it will be 
vitally important to determine whether the presence of viral 
particles in the myocardium of the explanted heart has any 
implications for the transplant patient’s management and 
prognosis. 
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